126 related articles for article (PubMed ID: 8612118)
1. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
Belchi-Hernandez J; Espinosa-Parra FJ
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
[TBL] [Abstract][Full Text] [Related]
2. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
[TBL] [Abstract][Full Text] [Related]
3. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S.
Yoshizawa S; Yasuoka A; Kikuchi Y; Honda M; Gatanaga H; Tachikawa N; Hirabayashi Y; Oka S
Ann Allergy Asthma Immunol; 2000 Sep; 85(3):241-4. PubMed ID: 11030281
[TBL] [Abstract][Full Text] [Related]
4. Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.
Roudier C; Caumes E; Rogeaux O; Bricaire F; Gentilini M
Arch Dermatol; 1994 Nov; 130(11):1383-6. PubMed ID: 7979438
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons.
Rich JD; Sullivan T; Greineder D; Kazanjian PH
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):409-14. PubMed ID: 9396972
[TBL] [Abstract][Full Text] [Related]
6. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
Jung AC; Paauw DS
Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
[TBL] [Abstract][Full Text] [Related]
8. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.
Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB
Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
10. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection].
Piketty C; Gilqouin J; Kazatchkine M
Ann Med Interne (Paris); 1996; 147(5):327-30. PubMed ID: 9033734
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
12. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature.
Ryan C; Madalon M; Wortham DW; Graziano FM
WMJ; 1998 May; 97(5):23-7. PubMed ID: 9617304
[TBL] [Abstract][Full Text] [Related]
13. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
White MV; Haddad ZH; Brunner E; Sainz C
Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
[TBL] [Abstract][Full Text] [Related]
14. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
[TBL] [Abstract][Full Text] [Related]
15. [Adverse reactions to trimethoprim-sulfamethoxazole in AIDS patients].
Irazábal B; Camino E; Cid de Rivera C; Aguirrebengoa K; Urkijo JC
Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):429-32. PubMed ID: 8260515
[TBL] [Abstract][Full Text] [Related]
16. TMP-SMX desensitization.
Posit Aware; 1995; ():7. PubMed ID: 11362574
[TBL] [Abstract][Full Text] [Related]
17. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection.
Anders HJ; Bogner JR; Goebel FD
Eur J Med Res; 1997 May; 2(5):198-200. PubMed ID: 9153343
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]